share_log

睿昂基因(688217.SH)股东浙江大健康减持55.76万股 减持期满

Ruiang Gene (688217.SH) zhejiang health shareholder reduces 0.5576 million shares when the shareholding period expires.

Zhitong Finance ·  Sep 27 16:04

Ruiang Gene (688217.SH) announced that on September 27, 2024, the company received from shareholder Zhejiang Dajiankang...

Smart Finance APP, Ruiang Gene (688217.SH) announced that on September 27, 2024, the company received a "Notice of the Expiry of the Period of the Shareholding Reduction Plan of Shanghai Ruiang Gene Technology Co., Ltd." issued by shareholder Zhejiang Dajiankang Equity Investment Fund (Limited Partnership) (referred to as "Zhejiang Dajiankang"). As of September 27, 2024, shareholder Zhejiang Dajiankang reduced the company's shares by 0.5576 million shares through centralized bidding trading, accounting for 0.9982% of the total share capital of the company. The time range of this shareholding reduction plan has expired.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment